Bausch Health Co. Inc. (BHC) Reports Q1 Revenue of $2.01 Billion, Lowers FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Bausch Health Companies Inc. Announces First-Quarter 2020 Results
May 7, 2020 6:59 AM EDTLAVAL, Quebec, May 7, 2020 /PRNewswire/ --
First-Quarter 2020 Financial Results Revenues of $2.012 Billion GAAP Net Loss of $152 Million Adjusted EBITDA (non-GAAP)1 of $813 Million GAAP Cash Generated from Operations of $261 Million Bausch + Lomb/International Segment Reported Revenue Was Flat, But Grew Organically1,2Â Compared to the First Quarter of 2019, Driven by Growth in the Global Consumer and International Rx Business Units Salix Segment Reported and Organic Revenues1,2Â Increased by 7% and 4% Respectively, Compared to the First Quarter of... More